TRADR 2X LONG SNPS DAILY ETF (SNPX) Stock Price, Forecast & Analysis

USA • NYSE Arca • NYSEARCA:SNPX • US46092D3439

27.11 USD
-4.44 (-14.08%)
At close: Feb 3, 2026
26.73 USD
-0.38 (-1.4%)
After Hours: 2/3/2026, 8:04:00 PM

SNPX Key Statistics, Chart & Performance

Key Statistics
Market Cap37.68M
Revenue(TTM)N/A
Net Income(TTM)-12.97M
Shares1.39M
Float1.36M
52 Week High43.54
52 Week Low1.84
Yearly Dividend0.82
Dividend Yield0%
EPS(TTM)-9.81
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2020-12-07
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
SNPX short term performance overview.The bars show the price performance of SNPX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 200 400 600 800

SNPX long term performance overview.The bars show the price performance of SNPX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 200 400 600 800

The current stock price of SNPX is 27.11 USD. In the past month the price decreased by -27.28%. In the past year, price increased by 812.52%.

TRADR 2X LONG SNPS DAILY ETF / SNPX Daily stock chart

SNPX Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to SNPX. When comparing the yearly performance of all stocks, SNPX is one of the better performing stocks in the market, outperforming 99.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SNPX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC15.54398.827B
AMGN AMGEN INC15.03182.324B
GILD GILEAD SCIENCES INC16.04177.765B
VRTX VERTEX PHARMACEUTICALS INC22.87118.135B
REGN REGENERON PHARMACEUTICALS16.3479.79B
ALNY ALNYLAM PHARMACEUTICALS INC49.1246.476B
INSM INSMED INC N/A33.518B
NTRA NATERA INC N/A31.422B
BIIB BIOGEN INC11.4425.931B
UTHR UNITED THERAPEUTICS CORP16.2320.594B

Related stock screener links

View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find more ETFs on the USA exchanges | Find stocks with similar TA and Setup ratings on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges

TRADR 2X LONG SNPS DAILY ETF / SNPX FAQ

What does TRADR 2X LONG SNPS DAILY ETF do?

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2020-12-07. The firm is principally focused on developing a product platform based upon a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer’s disease (AD), which is in the clinical testing stage. Preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The firm is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing.


What is the stock price of TRADR 2X LONG SNPS DAILY ETF today?

The current stock price of SNPX is 27.11 USD. The price decreased by -14.08% in the last trading session.


What is the ChartMill technical and fundamental rating of SNPX stock?

SNPX has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.